(Q42257816)

English

Durable antibody responses following one dose of the bivalent human papillomavirus L1 virus-like particle vaccine in the Costa Rica Vaccine Trial

scientific article published on November 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Durable antibody responses following one dose of the bivalent human papillomavirus L1 virus-like particle vaccine in the Costa Rica Vaccine Trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

0 references

9

object named as

Mark Schiffman

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Sholom Wacholder

8

object named as

Sholom Wacholder

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Ana Cecilia Rodríguez

10

object named as

Ana C Rodriguez

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Rolando Herrero

11

object named as

Rolando Herrero

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Douglas R. Lowy

7

object named as

Douglas R Lowy

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Carolina Vargas-Porras

2

object named as

Carolina Porras

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

18

object named as

CVT Group

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Aimée R. Kreimer

4

object named as

Aimee Kreimer

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Leen-Jan van Doorn

15

object named as

Leen-Jan van Doorn

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Mahboobeh Safaeian

1

object named as

Mahboobeh Safaeian

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

14

object named as

Wim Quint

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

17

object named as

Ligia A Pinto

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Allan Hildesheim

16

object named as

Allan Hildesheim

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

author name string

Yuanji Pan

3

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

John T Schiller

5

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Paula Gonzalez

6

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Troy Kemp

12

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Gloriana Shelton

13

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

publication date

1 November 2013

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Cancer Prevention Research

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

1242-1250

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Age of recipient and number of doses differentially impact human B and T cell immune memory responses to HPV vaccination.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24189371

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human papillomavirus 16 (HPV 16) and HPV 18 antibody responses measured by pseudovirus neutralization and competitive Luminex assays in a two- versus three-dose HPV vaccine trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/24189371

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatitis B vaccination: a completed schedule enough to control HBV lifelong? Milan, Italy, 17-18 November 2011.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24189371

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Kinetic and HPV infection effects on cross-type neutralizing antibody and avidity responses induced by Cervarix(®)

1 reference

https://pubmed.ncbi.nlm.nih.gov/24189371

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Highly effective detection of human papillomavirus 16 and 18 DNA by a testing algorithm combining broad-spectrum and type-specific PCR.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24189371

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safety and persistent immunogenicity of a quadrivalent human papillomavirus types 6, 11, 16, 18 L1 virus-like particle vaccine in preadolescents and adolescents: a randomized controlled trial.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24189371

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of antibody concentration and avidity in antiviral protection.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24189371

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus

1 reference

https://pubmed.ncbi.nlm.nih.gov/24189371

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pattern recognition by B cells: the role of antigen repetitiveness versus Toll-like receptors.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24189371

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Duration of humoral immunity to common viral and vaccine antigens

1 reference

https://pubmed.ncbi.nlm.nih.gov/24189371

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Correlates of protection induced by vaccination

1 reference

https://pubmed.ncbi.nlm.nih.gov/24189371

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Papillomavirus virus-like particles induce cytokines characteristic of innate immune responses in plasmacytoid dendritic cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/24189371

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mechanisms that determine plasma cell lifespan and the duration of humoral immunity.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24189371

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A review of clinical trials of human papillomavirus prophylactic vaccines

1 reference

https://pubmed.ncbi.nlm.nih.gov/24189371

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Proof-of-principle evaluation of the efficacy of fewer than three doses of a bivalent HPV16/18 vaccine

1 reference

https://pubmed.ncbi.nlm.nih.gov/24189371

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

1 reference

https://pubmed.ncbi.nlm.nih.gov/24189371

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunogenicity and reactogenicity of alternative schedules of HPV vaccine in Vietnam: a cluster randomized noninferiority trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/24189371

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sustained immunogenicity and efficacy of the HPV-16/18 AS04-adjuvanted vaccine: up to 8.4 years of follow-up

1 reference

https://pubmed.ncbi.nlm.nih.gov/24189371

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prospects for new human papillomavirus vaccines

1 reference

https://pubmed.ncbi.nlm.nih.gov/24189371

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic

1 reference

https://pubmed.ncbi.nlm.nih.gov/24189371

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Global cancer statistics, 2002

1 reference

https://pubmed.ncbi.nlm.nih.gov/24189371

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunogenicity and safety of the HPV-16/18 AS04-adjuvanted vaccine administered as a 2-dose schedule compared with the licensed 3-dose schedule: results from a randomized study

1 reference

https://pubmed.ncbi.nlm.nih.gov/24189371

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention of persistent human papillomavirus infection by an HPV16/18 vaccine: a community-based randomized clinical trial in Guanacaste, Costa Rica

1 reference

https://pubmed.ncbi.nlm.nih.gov/24189371

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The coming of age of virus-like particle vaccines

1 reference

https://pubmed.ncbi.nlm.nih.gov/24189371

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of systemic and mucosal anti-HPV16 and anti-HPV18 antibody responses from vaccinated women

1 reference

https://pubmed.ncbi.nlm.nih.gov/24189371

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Correlation between direct ELISA, single epitope-based inhibition ELISA and pseudovirion-based neutralization assay for measuring anti-HPV-16 and anti-HPV-18 antibody response after vaccination with the AS04-adjuvanted HPV-16/18 cervical cancer vacc

1 reference

https://pubmed.ncbi.nlm.nih.gov/24189371

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rationale and design of a community-based double-blind randomized clinical trial of an HPV 16 and 18 vaccine in Guanacaste, Costa Rica

1 reference

https://pubmed.ncbi.nlm.nih.gov/24189371

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Investigation of the detoxification mechanism of formaldehyde-treated tetanus toxin

1 reference

https://pubmed.ncbi.nlm.nih.gov/24189371

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epidemiological study of anti-HPV16/18 seropositivity and subsequent risk of HPV16 and -18 infections

1 reference

https://pubmed.ncbi.nlm.nih.gov/24189371

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safety and immunogenicity trial in adult volunteers of a human papillomavirus 16 L1 virus-like particle vaccine

1 reference

https://pubmed.ncbi.nlm.nih.gov/24189371

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1158/1940-6207.CAPR-13-0203

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

PMC publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42257816&oldid=1940345826"